As cannabis and cryptocurrencies have seen mainstream profile increases alongside one another,  both industries have earned their fair share of supporters and critics. One Wall Street expert, however, has his mind set on one.

Jason Karp, founder and portfolio manager of Tourbillon Capital Partners said on the Opportunities in Public and Private Markets podcast on May 8 that he believes investing in cannabis is a more important sector to take into consideration over cryptos.

“I think it is almost insane if you are an investor of any kind–public or private–to not have a strong opinion and not have basic knowledge on what’s going on with cannabis,” Karp said. “I would go so far as to say I think it’s far more important to be knowledgeable on this than it is to be on crypto.”

Despite being initially against the drug, Karp experimented with it by attempting to treat his insomnia and did research based on a friend’s request. After that, he was converted to the industry.

“I realized that I was going to spend a lot more time on the research from an investment perspective of this because this is a $50 billion industry today, [where] only $6 to $8 billion is legal,” Karp said. “My belief is the dominos are falling now to progressively increase the legalization timeline.”

Karp’s firm describes itself as an alternative asset management firm, employing low net exposure and “fundamentally driven long/short equity strategy.”

The Wall Street expert didn’t detail on the podcast specific stocks or companies he recommends but did mention he would not invest in the Canadian billion dollar valuated cannabis companies.

Karp favors cannabis over crypto due to cash flow

In terms of cryptocurrencies, Karp explained he views the crypto business as employing the “greater fool theory,” meaning holding assets under the belief there will always be someone willing to pay a higher price for them.

“Betting on a cryptocurrency is betting that someone is going to pay you more for the same thing that you bought without any cash flow generation,” Karp said. “Whereas with [cannabis] if your cash flows grow, you could be wrong on whether people want to buy it from you or not but you still win.”

During the show, host Patrick O’Shaughnessy, CEO of O’Shaughnessy Asset Management, said whenever he meets with groups of investors in Canada, he gets more questions about the cannabis space than crypto–mostly due to the encouragement the industry has seen from the legalization process.

“That’s a foreign concept here in the US still, because of the legalization problem but what an interesting area of the market,” O’Shaughnessy said.

The Canadian federal government is set to legalize the drug for recreational consumption later this year after the actual bill obtains approval from the Senate. While the US is moving towards legalization with states individually voting on this decision,  despite the drug remaining illegal federally under the Controlled Substances Act (CSA). However, this year has seen an increase in decriminalization bills from US senators.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less